Dimerix Ltd (ASX:DXB, OTC:SBMJF) has moved to strengthen the clinical and regulatory footing of its lead kidney disease ...
Stockhead on MSN
Health Check: Syntara goes to the well for $10 million to fund advanced cancer trial
Myelofibrosis drug developer Syntara has gone to the well for $10m, the latest biotech to tap the market in a ... Read More ...
For AV Technology readers who might think the NAB Show is just for radio and television broadcasters, think again. For at ...
Marvin T. Milk a.k.a. MM from The Boys is the group's level-headed, loving, and oft-frustrated medic with a God-tier T-Shirt ...
Q1 2026 Earnings Call May 4, 2026 4:30 PM EDTCompany ParticipantsTraci McCarty - Group Vice PresidentAlexander Hardy ...
Clinuvel Pharmaceuticals (ASX:CUV) is conducting a Phase III trial to expand the indications for Scenesse (afamelanotide), ...
Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a ...
A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
With more than 50 years of innovation and leadership in linear lighting solutions, Tivoli Lighting announces the launch of VAST EX Grazer, a high-output exterior linear lighting system engineered to ...
In a volatile market, Morgans healthcare analyst Iain Wilkie told Stockhead upcoming catalysts were likely to remain a key ...
Wolters Kluwer, a global leader in professional information, software solutions and services, today announced two new AI-powered enhancements to its Financial & Corporate Compliance (FCC) portfolio: ...
Section: Midnight Distributor: A24 Director: Ian Tuason Buzz: A micro-budget horror movie in the vein of “Paranormal Activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results